Abstract
Characteristics and anticancer interventions (ACIs) in African American (AA) and Caucasian (CAU) patients (pts) treated with sipuleucel-T (sip-T): Real-world experience from the PROCEED registry
Journal of clinical oncology, v 34(15_suppl), pp 5025-5025
20 May 2016
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Abstract only
Metrics
2 Record Views
Details
- Title
- Characteristics and anticancer interventions (ACIs) in African American (AA) and Caucasian (CAU) patients (pts) treated with sipuleucel-T (sip-T): Real-world experience from the PROCEED registry
- Creators
- Andrew J. Armstrong - Duke Medical CenterCelestia S. Higano - Fred Hutch Cancer CenterMatthew R. Cooperberg - University of California, San FranciscoChiledum Ahaghotu - Howard University HospitalRonald F. Tutrone - Chesapeake Urology AssociatesLaurence H. Belkoff - Urology AssociatesCarl A. Olsson - Icahn School of Medicine at Mount SinaiSanjay Goel - Montefiore Medical CenterRobert Claude Tyler - DendreonNancy N. Chang - DendreonJennifer Susan LIll - DendreonA. Oliver Sartor - Tulane University
- Publication Details
- Journal of clinical oncology, v 34(15_suppl), pp 5025-5025
- Publisher
- AMER SOC CLINICAL ONCOLOGY; ALEXANDRIA
- Number of pages
- 1
- Resource Type
- Abstract
- Language
- English
- Academic Unit
- Surgery
- Web of Science ID
- WOS:000404711501002
- Other Identifier
- 991021916913304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Oncology